倍他乐克、依那普利、安体舒通联合治疗慢性充血性心力衰竭对心室重构的影响
摘要
目的:观察倍他乐克、依那普利、安体舒通联合治疗慢性充血性心力衰竭(CHF)对心室重构的影响。方法:心衰患者随机分为倍他乐克组与倍他乐克+依那普利+安体舒通组。治疗后3个月测定心功能与左室内径等指标。结果:三药联合LVEDD、LVESD显著下降,LVEF增加显著,与倍他乐克组比较有显著差异性(P<0.05)。结论:三药联合老年性CHF较单独应用倍他乐克能更好地改善心衰,预防左室重构。
二级参考文献23
-
1[1]CARSON P. β-blocker therapy in heart failure[J]. Cardiology Clinics, 2001, 19(2):267-278.
-
2[2]PACKER M, BRISTOW MR, COHN JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med, 1996, 334(21):1349-1355.
-
3[3]GREENBERG B, QUINONES MA, KOILPILLAI C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction[J]. Circulation, 1995, 91(10):2573-2581.
-
4[4]BRISTOW MR, O'CONNELL JB, GILBERT EM, et al. Dose-response of chronic beta blocker treatment in heart failure from either idiopathic dilated or ischaemic cardiomyopathy[J]. Circulation, 1994, 89(4):1632-1642.
-
5[5]HALL SA, CIGARROA CG, MARCOUS L, et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade[J]. J Am Coll Cardiol, 1995, 25(5):1154-1161.
-
6[6]HASENFUSS G, HOLIBARSH C, HERMANN HP, et al. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with nonfailing hearts and in patients with nonfailing hearts and in patients with dilated cardiomyopathy[J]. Eur Heart J, 1994, 15(1):164-170.
-
7[7]WAAGSTEIN F, HJALMARSON A, VARNAUSKAS E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy[J]. Br Heart J, 1975, 37(10):1022-1036.
-
8[8]ENGELMEIER RS, O'CONNELL JB, WALSH R, et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomised, placebo-controlled trial[J]. Circulation, 1985, 72(3):536-546.
-
9[9]WISENBAUGH T, KATZ I, DAVIS J, et al. Long-term(3 month) effects of a new beta-blocker( nebivolol) on cardiac performance in dilated cardiomyopathy[J]. J Am Coll Cardiol, 1993, 21(5):1094-1100.
-
10[10]KRUM H, SCHWARTZ B, SACKNER-BERNSTEIN J, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe heart failure treated with converting-enzyme inhibitors[J]. J Am Coll Cardiol, 1993, 21(2 Suppl A):114A.
共引文献47
-
1余德海.小剂量倍他乐克治疗慢性心力衰竭疗效观察[J].基层医学论坛,2003,7(12):1164-1165.
-
2刘莉,金娟,顾焕.慢性心力衰竭药物治疗概况[J].中医药信息,2004,21(4):6-8.
-
3胡燕红,巴丹.家族性扩张型心肌病2例[J].中国心血管杂志,2004,9(4):311-312.
-
4孔凡斌,李迁.卡托普利 安体舒通 美托洛尔联合治疗充血性心衰66例[J].成都医药,2004,30(6):350-351.
-
5欧阳平,谢晋国,刘俭,肖文星,刘彦波,王磊,梁东,王永华,许顶立,刘伊丽,徐安龙.重组海葵肽类毒素hk2a对急性心功能不全犬左心功能的影响[J].第一军医大学学报,2005,25(1):37-39. 被引量：2
-
6索朗来措,德吉央宗.心力衰竭的治疗进展[J].西藏科技,2005(2):35-35.
-
7王秀霞.慢性心功能不全的药物治疗进展[J].菏泽医学专科学校学报,2002,14(4):79-80.
-
8白宏兴,李小平.倍他乐克、依那普利、安体舒通联合治疗慢性充血性心力衰竭疗效观察[J].青海医药杂志,2005,35(5):23-24.
-
9吴桂杰.小剂量美托洛尔治疗慢性充血性心力衰竭疗效观察[J].华北煤炭医学院学报,2005,7(3):326-327.
-
10黄震华.卡维地洛在心力衰竭治疗中的应用[J].中国新药与临床杂志,2006,25(3):223-227. 被引量：7
-
1王芳.联合用药治疗风湿性心脏病慢性心衰的疗效分析[J].中国处方药,2014,12(3):46-46. 被引量：9
-
2唐玉梅.倍他乐克、依那普利、安体舒通联合治疗慢性充血性心力衰竭对心室重构的影响[J].中国当代医药,2009,16(6):23-24.
-
3王瑛,于凤秀.培哚普利、缬沙坦、螺内酯联合治疗慢性充血性心力衰竭的疗效观察[J].中国社区医师（医学专业）,2008,10(19):21-21. 被引量：2
-
4郑世香.曲美他嗪治疗冠心病并发慢性心功能不全的疗效观察[J].中国基层医药,2012,19(20):3088-3089. 被引量：6
-
5王瑛,于凤秀.倍他乐克、依那普利、安体舒通联合治疗慢性充血性心力衰竭对心室重构的影响[J].中国实用医药,2009,4(32):135-136.
-
6苏彦洲.胺碘酮联合替米沙坦治疗慢性心力衰竭合并阵发性房颤的临床效果[J].当代医学,2016,22(29):149-150.
